
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer
Deepthi Ramesh, Sònia Guil
Seminars in Cancer Biology (2022) Vol. 86, pp. 18-31
Open Access | Times Cited: 73
Deepthi Ramesh, Sònia Guil
Seminars in Cancer Biology (2022) Vol. 86, pp. 18-31
Open Access | Times Cited: 73
Showing 1-25 of 73 citing articles:
The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 172
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 172
Alternative splicing and related RNA binding proteins in human health and disease
Yining Tao, Qi Zhang, Haoyu Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 72
Yining Tao, Qi Zhang, Haoyu Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 72
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Synonymous mutations promote tumorigenesis by disrupting m6A-dependent mRNA metabolism
Yiheng Lan, Zhen Xia, Qizhe Shao, et al.
Cell (2025)
Closed Access | Times Cited: 2
Yiheng Lan, Zhen Xia, Qizhe Shao, et al.
Cell (2025)
Closed Access | Times Cited: 2
IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis
Ji-Fei Ding, He Sun, Kai Song, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175494-175494
Closed Access | Times Cited: 23
Ji-Fei Ding, He Sun, Kai Song, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175494-175494
Closed Access | Times Cited: 23
IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development
Lei Lv, Qinqin Wei, Jianxiao Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 12
Lei Lv, Qinqin Wei, Jianxiao Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 12
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance
Xuemeng Xu, Peng Qiu, Zongyao Ren, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xuemeng Xu, Peng Qiu, Zongyao Ren, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
Laura Casalino, Francesco Talotta, Ilenia Matino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8307-8307
Open Access | Times Cited: 22
Laura Casalino, Francesco Talotta, Ilenia Matino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8307-8307
Open Access | Times Cited: 22
WTAP‐induced N6 ‐methyladenosine of PD‐L1 blocked T‐cell‐mediated antitumor activity under hypoxia in colorectal cancer
Qizhi Liu, Nan Zhang, Junyi Chen, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1749-1762
Open Access | Times Cited: 7
Qizhi Liu, Nan Zhang, Junyi Chen, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1749-1762
Open Access | Times Cited: 7
WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells
Bo Wang, Yuting Wang, Wantong Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Bo Wang, Yuting Wang, Wantong Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
ALKBH5 controls the meiosis-coupled mRNA clearance in oocytes by removing the N 6-methyladenosine methylation
Long Bai, Xiang Yu, Minyue Tang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Long Bai, Xiang Yu, Minyue Tang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment
Wei Shao, Hui Zhao, Shoudu Zhang, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 14
Wei Shao, Hui Zhao, Shoudu Zhang, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 14
Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors
Heng Zhou, Qiang Sun, Ming-Liang Feng, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4247-4265
Open Access | Times Cited: 14
Heng Zhou, Qiang Sun, Ming-Liang Feng, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4247-4265
Open Access | Times Cited: 14
FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1
Chaoqin Guo, Nana Zhou, Yisong Lu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115955-115955
Open Access | Times Cited: 13
Chaoqin Guo, Nana Zhou, Yisong Lu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115955-115955
Open Access | Times Cited: 13
METTL14 depletion ameliorates ferroptosis in severe acute pancreatitis by increasing the N6-methyladenosine modification of ACSL4 and STA1
Feng Chen, Minghua Su, Dong Han, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111495-111495
Closed Access | Times Cited: 5
Feng Chen, Minghua Su, Dong Han, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111495-111495
Closed Access | Times Cited: 5
Targeting insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) for the treatment of cancer
Yuanqian Cai, Yingzhe Wang, Bingjie Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116241-116241
Closed Access | Times Cited: 5
Yuanqian Cai, Yingzhe Wang, Bingjie Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116241-116241
Closed Access | Times Cited: 5
N6-Methyladenosine–Modified KREMEN2 Promotes Tumorigenesis and Malignant Progression of High-Grade Serous Ovarian Cancer
Rui Hou, Yadong Wang, Shiyao Cao, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 6, pp. 102059-102059
Closed Access | Times Cited: 5
Rui Hou, Yadong Wang, Shiyao Cao, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 6, pp. 102059-102059
Closed Access | Times Cited: 5
ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner
Jinhao Chen, Mujie Ye, Jian’an Bai, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Jinhao Chen, Mujie Ye, Jian’an Bai, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
The m6A reader IGF2BP1 attenuates the stability of RPL36 and cell proliferation to mediate benzene hematotoxicity by recognizing m6A modification
Jingyu Wang, Xiaoli Guo, Yujiao Chen, et al.
Toxicology (2024) Vol. 503, pp. 153758-153758
Closed Access | Times Cited: 4
Jingyu Wang, Xiaoli Guo, Yujiao Chen, et al.
Toxicology (2024) Vol. 503, pp. 153758-153758
Closed Access | Times Cited: 4
GAS5 regulated by FTO-mediated m6A modification suppresses cell proliferation via the IGF2BP2/QKI axis in breast cancer
Yuzhao Yan, Jing Ma, Qingqiu Chen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Yuzhao Yan, Jing Ma, Qingqiu Chen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
WTAP and METTL14 regulate the m6A modification of DKK3 in renal tubular epithelial cells of diabetic nephropathy
Kang Fu, Chenyang Jing, Jin‐Song Shi, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 738, pp. 150524-150524
Closed Access | Times Cited: 4
Kang Fu, Chenyang Jing, Jin‐Song Shi, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 738, pp. 150524-150524
Closed Access | Times Cited: 4
Research Note: Detection of IGF2BP2 gene polymorphism associated with growth and reproduction traits of pigeon
Yuling Wu, Shudai Lin, Lihong Gu, et al.
Poultry Science (2025) Vol. 104, Iss. 3, pp. 104834-104834
Open Access
Yuling Wu, Shudai Lin, Lihong Gu, et al.
Poultry Science (2025) Vol. 104, Iss. 3, pp. 104834-104834
Open Access
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access